Companies: 10,795·Total market cap: $144.5T
SOPHiA GENETICS S.A.

SOPHiA GENETICS S.A.

SOPHNASDAQHealthcare● Active
$5.38
+$0.38(+7.50%)
Market Cap$385219263
P/E Ratio
52W High$5.7
52W Low$2.59

SOPHiA GENETICS S.A. (SOPH) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

soph · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 7 Wall Street analysts in the past 3 months

SellBuy

Buy

7 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
6
Hold
1
Sell
0
Strong Sell
0
Total: 7 · Buy rate: 85.7%

12-Month Price Target

High

$8.00

Consensus

$7.50

+42.0% upside

Low

$7.00

Median: $7.5 · Last Close: $5.28

The SOPHiA GENETICS S.A. (SOPH) analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month SOPH price target is $7.50, representing +42.0% upside from the current price of $5.28.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $8 (42.0%)

Consensus Target

$7.50

42.0% upside

High Target

$8

51.5%

Low Target

$7

32.6%

Current Price

$5.28

as of today

Based on analyst price targets, the SOPH stock price prediction for the next 12 months ranges from $7 to $8. The consensus SOPH price forecast of $7.50 implies 42.0% upside from the current price of $5.28.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$5.351.35%

1-day model range: $5.32–$5.39. Peak: $5.39 (+1.35%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$5-1.5%
2028$5-2.3%
2029$5-2.7%
2030$5-3.0%
2031-3.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)69.0Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · SOPH · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$4.99BUY
MA 10$5.02BUY
MA 20$4.88BUY
MA 50$4.97BUY
MA 100$4.91BUY
MA 200$4.59BUY
Current $SOPH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.06BUY
EMA 10$5.01BUY
EMA 20$4.97BUY
EMA 50$4.94BUY
EMA 100$4.85BUY
EMA 200$4.59BUY
Current $SOPH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BTIG2026-05-06
Maintains
BuyBuy
BTIG2026-04-15
Maintains
BuyBuy
Guggenheim2026-01-26
Maintains
BuyBuy
BTIG2025-11-10
Maintains
BuyBuy
RBC Capital2024-08-07
Maintains
OutperformOutperform
BTIG2024-03-06
Maintains
BuyBuy
RBC Capital2024-03-06
Maintains
OutperformOutperform
RBC Capital2024-01-12
Maintains
OutperformOutperform
Credit Suisse2023-05-10
Maintains
NeutralNeutral
Morgan Stanley2023-05-10
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on SOPHiA GENETICS S.A. (SOPH) stock. Of the recent 22 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover SOPH.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

SOPH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$93M

↓ 33.4% YoY

Revenue Next Year

$112M

↑ 20.3% YoY

EPS This Year

$-0.87

EPS Next Year

$-0.66

↓ 24.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SOPH EPS of $-0.87 for the current fiscal year, based on estimates from 2 analysts. The SOPH revenue forecast is $93M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The SOPH stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SOPH price target is $7.50 (+42.0% upside), with an analyst consensus of Buy.

The SOPH short-term stock prediction for tomorrow is $5.35 (+1.35%). The SOPH stock price prediction for 2027 estimates an average of $5. The SOPH stock prediction for 2030 projects a range of $5–$5.

SOPHiA GENETICS S.A. trades on NASDAQ under the ticker SOPH. The SOPH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 86% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

SOPH forecast · 8 questions

According to 7 Wall Street analysts, the average 12-month SOPH price target is $7.50, with a high forecast of $8.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +42.0% potential upside from the current price of $5.28.

SOPH price targetWhat is SOPH price targetSOPH analyst price targetSOPH 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.